Literature DB >> 16087877

The striatofugal fiber system in primates: a reevaluation of its organization based on single-axon tracing studies.

Martin Lévesque1, André Parent.   

Abstract

The current model of basal ganglia rests on the idea that the striatofugal system is composed of two separate (direct and indirect) pathways originating from distinct cell populations in the striatum. The striatum itself is divided into two major compartments, the striosomes and the matrix, which differ by their neurochemical makeup and input/output connections. Here, neurons located in either striosomes or the extrastriosomal matrix in squirrel monkeys were injected with biotin dextran amine, and their labeled axons were entirely reconstructed with a camera lucida. Twenty-four of 27 reconstructed axons arborized into the three main striatal targets (external pallidum, globus pallidus, and substantia nigra pars reticulata), a finding that is at odds with the concept of a dual striatofugal system. Axons of striosomal neurons formed several columnar terminal fields in the substantia nigra pars reticulata. These data indicate that the substantia nigra pars compacta is neither the only nor the main target of striosomal neurons, a finding that calls for a reevaluation of the organization of the striatonigral projection system.

Entities:  

Mesh:

Year:  2005        PMID: 16087877      PMCID: PMC1187973          DOI: 10.1073/pnas.0502710102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

Review 1.  Extrinsic connections of the basal ganglia.

Authors:  A Parent
Journal:  Trends Neurosci       Date:  1990-07       Impact factor: 13.837

Review 2.  Neurotransmitters and neuromodulators in the basal ganglia.

Authors:  A M Graybiel
Journal:  Trends Neurosci       Date:  1990-07       Impact factor: 13.837

3.  The neostriatal mosaic: striatal patch-matrix organization is related to cortical lamination.

Authors:  C R Gerfen
Journal:  Science       Date:  1989-10-20       Impact factor: 47.728

4.  Evidence for autapses in the substantia nigra.

Authors:  A B Karabelas; D P Purpura
Journal:  Brain Res       Date:  1980-11-03       Impact factor: 3.252

5.  The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems.

Authors:  C R Gerfen; M Herkenham; J Thibault
Journal:  J Neurosci       Date:  1987-12       Impact factor: 6.167

6.  The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems.

Authors:  C R Gerfen
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

7.  Identification of different subpopulations of neostriatal neurones projecting to globus pallidus or substantia nigra in the monkey: a retrograde fluorescence double-labelling study.

Authors:  J Féger; A R Crossman
Journal:  Neurosci Lett       Date:  1984-08-24       Impact factor: 3.046

8.  The striatopallidal and striatonigral projections: two distinct fiber systems in primate.

Authors:  A Parent; C Bouchard; Y Smith
Journal:  Brain Res       Date:  1984-06-15       Impact factor: 3.252

9.  The distribution of dynorphinergic terminals in striatal target regions in comparison to the distribution of substance P-containing and enkephalinergic terminals in monkeys and humans.

Authors:  A Reiner; L Medina; S N Haber
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

Review 10.  Primate models of movement disorders of basal ganglia origin.

Authors:  M R DeLong
Journal:  Trends Neurosci       Date:  1990-07       Impact factor: 13.837

View more
  68 in total

Review 1.  Intrinsic and integrative properties of substantia nigra pars reticulata neurons.

Authors:  F-M Zhou; C R Lee
Journal:  Neuroscience       Date:  2011-08-02       Impact factor: 3.590

Review 2.  The external globus pallidus: progress and perspectives.

Authors:  Daniel J Hegeman; Ellie S Hong; Vivian M Hernández; C Savio Chan
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

Review 3.  The nucleus accumbens as part of a basal ganglia action selection circuit.

Authors:  Saleem M Nicola
Journal:  Psychopharmacology (Berl)       Date:  2006-09-16       Impact factor: 4.530

Review 4.  Movement disorders in 2013: diagnosing and treating PD-the earlier the better?

Authors:  François Tison; Wassilios G Meissner
Journal:  Nat Rev Neurol       Date:  2014-01-07       Impact factor: 42.937

5.  A biologically constrained model of the whole basal ganglia addressing the paradoxes of connections and selection.

Authors:  Jean Liénard; Benoît Girard
Journal:  J Comput Neurosci       Date:  2014-06       Impact factor: 1.621

Review 6.  The avian subpallium: new insights into structural and functional subdivisions occupying the lateral subpallial wall and their embryological origins.

Authors:  Wayne J Kuenzel; Loreta Medina; Andras Csillag; David J Perkel; Anton Reiner
Journal:  Brain Res       Date:  2011-09-24       Impact factor: 3.252

Review 7.  Pathophysiology of parkinsonism.

Authors:  Adriana Galvan; Thomas Wichmann
Journal:  Clin Neurophysiol       Date:  2008-05-07       Impact factor: 3.708

Review 8.  Neurocomputational models of basal ganglia function in learning, memory and choice.

Authors:  Michael X Cohen; Michael J Frank
Journal:  Behav Brain Res       Date:  2008-10-04       Impact factor: 3.332

9.  Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease.

Authors:  Benjamin R Miller; Adam G Walker; Anand S Shah; Scott J Barton; George V Rebec
Journal:  J Neurophysiol       Date:  2008-07-30       Impact factor: 2.714

10.  Vasoactive intestinal peptide (VIP) treatment of Parkinsonian rats increases thalamic gamma-aminobutyric acid (GABA) levels and alters the release of nerve growth factor (NGF) by mast cells.

Authors:  Orhan Tansel Korkmaz; Neşe Tunçel; Muzaffer Tunçel; Elif Mine Oncü; Varol Sahintürk; Mustafa Celik
Journal:  J Mol Neurosci       Date:  2009-12-02       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.